Laparoscopic adjustable gastric banding for the treatment of morbid (grade 3) obesity and its metabolic complications: A three-year study

Journal of Clinical Endocrinology and Metabolism

Volumn 87, Issue 8, 2002, Pages 3555-3561

  Pontiroli, Antonio E ^a,b   Pizzocri, Pierluigi ^b   Librenti, Maria Cristina ^c   Vedani, Paola ^c   Marchi, Monica ^d   Cucchi, Emanuele ^a   Orena, Corrado ^b   Paganelli, Michele ^c   Giacomelli, Maurizio ^c   Ferla, Gianfranco ^d   Folli, Franco ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Ospedale San Paolo   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL; URIC ACID;

ADULT; ARTERIAL PRESSURE; ARTICLE; BODY FAT; BODY WEIGHT; CONTROLLED STUDY; FEMALE; FOLLOW UP; GASTRIC BANDING; HEMOGLOBIN DETERMINATION; HUMAN; LAPAROSCOPIC SURGERY; MAJOR CLINICAL STUDY; MALE; MORBID OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL;

EID: 18544384995     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.87.8.8708     Document Type: Article

References (46)

1. Varying body mass index cutoff points to describe overweight prevalence among U.S. adults: NHANES III (1988 to 1994)
2. Overweight and obesity in the United States: Prevalence and trends, 1960-1994
3. Rapid changes in the prevalence of obesity and known diabetes in an adult Norwegian population. The Nord-Trondelag Health Surveys: 1984-1986 and 1995-1997
4. A prospective study of obesity and risk of coronary heart disease in women
5. Body-mass index and mortality in a prospective cohort of U.S. adults
6. Definition and health consequences of morbid obesity
7. Natural history of glucose intolerance in obesity. A ten year observation
8. Effect of past and concurrent body mass index on prevalence of glucose intolerance and Type 2 (non-insulin-dependent) diabetes and on insulin response
9. Duration of obesity increases the incidence of NIDDM
10. Duration of obesity is a risk factor for non-insulin-dependent diabetes mellitus, not for arterial hypertension or for hyperlipidemia
11. Left ventricular function response to exercise in normotensive obese subjects: Influence of degree and duration of obesity
12. Effect of body size, ponderosity, and blood pressure on left ventricular growth in children and young adults in the Bogalusa heart study
13. Secondary failure of oral hypoglycaemic agents: Frequency, possible causes, and management
14. Effect of insulin therapy on blood pressure in NIDDM patients with secondary failure
15. Effect of obesity on the response to insulin therapy in non-insulin-dependent diabetes mellitus
16. Is insulin the only treatment for obese NIDDM patients poorly controlled by oral hypoglycemic agents?
17. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus
18. Weight loss in severely obese subjects prevents the progression of impaired glucose tolerance to type II diabetes. A longitudinal interventional study
19. Reoperative surgery for the morbidly obese
20. Prospective study of a laparoscopically placed, adjustable gastric band in the treatment of morbid obesity
21. Invited commentary: Swedish adjustable gastric banding
22. Thirty months experience with laparoscopic adjustable gastric banding
23. Physical status: The use and interpretation of anthropometry: Report of a WHO expert committee
24. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: The evidence report
25. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation
26. Adipose tissue determinations in cadavers - A comparison between cross-sectional planimetry and computed tomography
27. Total and intra-abdominal fat measurements by ultrasound and computerized tomography
28. The Yale-Brown-Cornell Eating Disorder Scale: Development, use, reliability and validity
29. National Institute of Mental Health Diagnostic Interview Schedule. Its history, characteristics, and validity
30. Homeostasis model assessment: Insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man
31. Liver abnormalities in severely obese subjects: Effect of drastic weight loss after gastroplasty
32. Automated enzymatic determination of plasma free fatty acids by centrifugal analysis
33. Feasibility of centralized measurements of glycated hemoglobin in the Diabetes Control and Complications Trial: A multicenter study
34. Role of insulin resistance in human disease
35. Hypertriglyceridemia and hyperinsulinemia are potent inducers of endothelin-1 release in humans
36. Metabolic implications of body fat distribution
37. Averting the U.S. epidemics: Does weight loss help?
38. Treatment of obesity by moderate and severe caloric restriction. Results of clinical research trials
39. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
40. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
41. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research
42. Overview of JNC VI: New directions in the management of hypertension and cardiovascular risk
43. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
44. Medicinal strategies in the treatment of obesity
45. Beneficial effect of diazoxide in obese hyperinsulinemic adults
46. Differentiated long-term effects of intentional weight loss on diabetes and hypertension